Category: Biopharmaceuticals
Global Biopharmaceuticals
-
Leukemia Therapeutics Market - By Leukemia Type (Acute Lymphocytic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), By Treatment Type (Targeted Drugs & Immunotherapy, Chemotherapy, By Molecule Type (Small Molecules, Biologics, By Mode Of Administration (Injectable, Oral) - Global Industry Perspective, Comprehensive Analysis And Forecast, 2021-2030
... Molecules, Biologics, By Mode Of Administration (Injectable, Oral) - Global Industry Perspective, Comprehensive Analysis And Forecast, 2021-2030 Market Overview Fatpos Global has released a report titled Leukemia Therapeutics Market - Analysis of Market Size, Share ... Read More
-
Pharmaceutical Sterility Testing Market - By Type (In-House And Outsourcing), By Test Type (Sterility Testing, Bioburden Testing, And Bacterial Endotoxin Testing), By Sample (Sterile Drugs, Medical Devices, And Biologics & Therapeutics), By End-Use (Compounding Pharmacies, Medical Devices Companies, And Pharmaceutical Companies), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 – 2030
... Medical Devices Companies, And Pharmaceutical Companies), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 – 2030 Market Overview Fatpos Global has released a report titled Pharmaceutical Sterility Testing Market - Analysis of ... Read More
-
Biopharmaceuticals Market by Product (Monoclonal Antibody, Interferon, Insulin, Growth and Coagulation Factor, Erythropoietin, Vaccine, Hormone, And Others) and by Application (Oncology, Blood Disorder, Metabolic Disease, Infectious Disease, Cardiovascular Disease, Neurological Disease, Immunology, And Others)- Global Opportunity Analysis and Industry Forecast 2022-2030
... Opportunity Analysis and Industry Forecast 2022-2030 The Biopharmaceuticals Market was valued at USD 345.84 billion in 2021 and is predicted to reach USD 974.48 billion by 2030 with a CAGR of 11.7% from 2022-2030. Biopharmaceutical ... Read More
-
Biosimilar Market Trends 2019
... therapeutic equivalents of brand name drugs. However, biosimilars are not generic biologics because there can be no generic form of biologics due to the complex process of creating biologics. Biosimilar Market Trends 2019 is designed ... Read More
-
Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics
... Biologics Summary The Global Biosimilar market by product is projected to grow at a compound annual growth rate (CAGR) of 45.22%. The market is driven mainly by a constrained payer environment and patent expiration of ... Read More
-
World Market for Biopharmaceutical Drug Delivery Device Technology
... injections are not the first choice among patients and compliance is an ongoing issue. Further, as the majority of new entities in development are biologics requiring advanced drug delivery, manufacturers of devices have been busy ... Read More
-
In Vitro Toxicology Market
... study aims to derive crucial insights that will benefit all the major stakeholders of the industry in developing strategic business plans based on these emerging trends. The report provides market size and growth trends for ... Read More
-
Global Contract Biopharmaceuticals
... include commercial manufacturing and contract manufacturing. Major world regions include US, Western Europe, China, India, and all other regions. To illustrate historical trends, world, service, and regional demand are provided in annual series for 2012-2017. Read More
-
Biosimilars: Global Market, Trends and Competitor Analysis
... a complete picture of the biosimilars market, including information on the world, United States, EU, Germany, France, UK, Italy Spain, rest of Europe, Russia, Japan, India, China, South Korea, Australia, Brazil, Mexico, Turkey, Iran, Canada ... Read More
Research Assistance
